Entera Bio Ltd (ENTX)

03:28 AM

ENTX SEC FilingsEntera Bio Ltd 10-K, 10-Q, 8-K Forms - Stock Titan

03:28 AM

02:31 AM

Entera Bio Ltd. (ENTX) Presents at Endocrine Society's Annual Meeting (ENDO 2026)Slideshow - Seeking Alpha

02:31 AM

Jun 15, 2026

Entera Bio presents Phase 1 data on single-tablet EB613 - Investing.com

Jun 15, 2026

Jun 15, 2026

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis) - Yahoo Finance

Jun 15, 2026

Jun 10, 2026

Entera Bio (ENTX) Slides 4.1% as Selling Pressure Tests Key Support at $1.11Long Term Entry Picks - newsline.com

Jun 10, 2026

Jun 09, 2026

ENTX Q1 2026 Earnings: Surprise EPS Beat as Operating Loss NarrowsEarnings Beat Alert - newsline.com

Jun 09, 2026

Jun 04, 2026

ENTX | Entera Bio Ltd. Ordinary Executive Compensation - Quiver Quantitative

Jun 04, 2026

Jun 04, 2026

Entera Bio (ENTX) Holds Steady at $1.22 as Stock Consolidates Near SupportElliott Wave Count - newsline.com

Jun 04, 2026

Jun 03, 2026

[ARS] Entera Bio Ltd. SEC Filing - Stock Titan

Jun 03, 2026

Jun 03, 2026

Entera Bio (NASDAQ: ENTX) 2026 proxy seeks board, equity plan and share capital approvals - Stock Titan

Jun 03, 2026

Jun 01, 2026

Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX) - TipRanks

Jun 01, 2026

Jun 01, 2026

Entera Bio Q1 2026 Earnings: Wider Loss Narrows on EPS Beat, Yet Shares SlideStrong Earnings Momentum - newsline.com

Jun 01, 2026

May 29, 2026

ENTX Q1 2026 Earnings: Better-than-Expected Losses Reflect Clinical ProgressAdjusted Earnings Analysis - The Legal Advocate

May 29, 2026

May 28, 2026

Entera Bio presents clinical data on osteoporosis candidate By Investing.com - Investing.com Nigeria

May 28, 2026

May 28, 2026

Entera Bio presents clinical data on osteoporosis candidate - Investing.com

May 28, 2026

May 28, 2026

Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for OsteoporosisSingle Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation - The Manila Times

May 28, 2026

May 28, 2026

Experimental osteoporosis pill gets late-breaking ENDO 2026 slot - Stock Titan

May 28, 2026

May 27, 2026

ENTX Q1 2026 Earnings: Narrower-than-Expected Loss Reflects Cost Discipline Amid Pre-Revenue StageROA Comparison - newsline.com

May 27, 2026

May 26, 2026

ENTX - Finviz

May 26, 2026

May 25, 2026

Entera Bio Ltd. (ENTX) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Strong Earnings BeatRevenue Estimate Trend - Newser

May 25, 2026

May 23, 2026

Entera Bio (ENTX) Q1 2026 Earnings: Narrowing Losses as Cash Burn Remains in FocusEarnings Revision Report - The Legal Advocate

May 23, 2026

May 22, 2026

Entera Bio (ENTX) Faces Selling Pressure as Stock Dips Below Key ResistancePrice Action Signals - newser.com

May 22, 2026

May 18, 2026

[EFFECT] Entera Bio Ltd. SEC Filing - Stock Titan

May 18, 2026

May 15, 2026

Entera Bio (NASDAQ: ENTX) registers 19.6M shares; $14.5M possible on warrant exercises - Stock Titan

May 15, 2026

May 15, 2026

Entera Bio Ltd.Ordinary Shares (NQ: ENTX - FinancialContent

May 15, 2026

May 14, 2026

Entera Bio (ENTX) shareholder vote set for July 14, 2026; 2.5M-share plan increase - Stock Titan

May 14, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 10, 2026

Number of shareholders of Entera Bio Ltd. – HAM:5DT - TradingView

May 10, 2026

May 09, 2026

MSN Money - MSN

May 09, 2026

May 09, 2026

Entera Bio Sees Funding Sufficient Through 1Q27 >ENTX - Moomoo

May 09, 2026

May 08, 2026

Entera Bio Highlights Q1 2026 Progress and Financing - TipRanks

May 08, 2026

May 08, 2026

Entera Bio (ENTX) grants COO 72,993 RSUs in lieu of cash bonus - Stock Titan

May 08, 2026

May 08, 2026

Entera Bio (ENTX) CFO receives 58,394 RSUs through A2Z Counseling Ltd. - Stock Titan

May 08, 2026

May 08, 2026

Entera Bio (ENTX) awards 87,591 RSUs to Chief of R&D Burshtein - Stock Titan

May 08, 2026

May 08, 2026

Entera Bio Ltd. (NASDAQ: ENTX) registers 19.6M shares for resale under S-3 - Stock Titan

May 08, 2026

May 08, 2026

Entera Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 08, 2026

May 08, 2026

Entera Bio (ENTX) widens Q1 loss as R&D doubles and cash runway nears Q1 2027 - Stock Titan

May 08, 2026

May 08, 2026

Entera pushes an osteoporosis pill toward Phase 3 as cash hits $20.4M - Stock Titan

May 08, 2026

May 08, 2026

Entera Bio (NASDAQ: ENTX) details Q1 2026 loss and cash runway to 2027 - Stock Titan

May 08, 2026

May 08, 2026

Press Release: Entera Announces First Quarter 2026 Financial Results and Updates Across Its Oral Peptide Programs - Moomoo

May 08, 2026

May 08, 2026

Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs - GlobeNewswire

May 08, 2026

May 06, 2026

How Entera Bio (ENTX) performance reflects its true potential (Smart Money Flows) 2026-05-06Verified Stock Signals - newser.com

May 06, 2026

May 05, 2026

Entera Bio (ENTX) upgraded to buy: Here's what you should know - MSN

May 05, 2026

May 01, 2026

Entera Bio (ENTX) to Release Earnings on Friday - MarketBeat

May 01, 2026

Apr 29, 2026

Entera Bio (ENTX) Upgraded to Buy: Here's What You Should Know - sharewise.com

Apr 29, 2026

Apr 29, 2026

HC Wainwright Has Strong Estimate for Entera Bio Q1 Earnings - MarketBeat

Apr 29, 2026

Apr 28, 2026

What is HC Wainwright's Estimate for Entera Bio Q1 Earnings? - MarketBeat

Apr 28, 2026